World's Best Scientists 2026 revealed!

D-Index & Metrics

Chemistry

D-Index
48
Citations
14986
World Ranking
15042
National Ranking
112

Dan Gibson publication distribution in Chemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Chemistry in 2026. The highlighted bar marks where Dan Gibson sits on this spectrum.

61–80 publications: 66 scientists 81–100 publications: 302 scientists 101–120 publications: 623 scientists 121–140 publications: 918 scientists 141–160 publications: 1,218 scientists 161–180 publications: 1,350 scientists 181–200 publications: 1,344 scientists 201–220 publications: 1,281 scientists 221–240 publications: 1,216 scientists 241–260 publications: 1,100 scientists 261–280 publications: 979 scientists 281–300 publications: 939 scientists 301–320 publications: 764 scientists 321–340 publications: 643 scientists 341–360 publications: 628 scientists 361–380 publications: 522 scientists 381–400 publications: 459 scientists 401–420 publications: 397 scientists 421–440 publications: 327 scientists 441–460 publications: 270 scientists 461–480 publications: 265 scientists 481–500 publications: 252 scientists 501–520 publications: 201 scientists 521–540 publications: 185 scientists 541–560 publications: 148 scientists 561–580 publications: 148 scientists 581–600 publications: 132 scientists 601–620 publications: 114 scientists 621–640 publications: 104 scientists 641–660 publications: 91 scientists 661–680 publications: 92 scientists 681–700 publications: 73 scientists 701–720 publications: 57 scientists 721–740 publications: 54 scientists 741–760 publications: 67 scientists 761–780 publications: 45 scientists 781–800 publications: 46 scientists 801–820 publications: 39 scientists 821–840 publications: 32 scientists 841–860 publications: 36 scientists 861–880 publications: 29 scientists 881–900 publications: 26 scientists 901–920 publications: 24 scientists 921–940 publications: 14 scientists 941–960 publications: 23 scientists 961–980 publications: 28 scientists 981–1,000 publications: 15 scientists 1,001–1,020 publications: 29 scientists 1,021–1,040 publications: 12 scientists 1,041–1,060 publications: 19 scientists 1,061–1,080 publications: 12 scientists 1,081–1,100 publications: 6 scientists 1,101–1,120 publications: 8 scientists 1,121–1,140 publications: 12 scientists 1,141–1,160 publications: 5 scientists 1,161–1,180 publications: 6 scientists 1,181–1,200 publications: 14 scientists 1,201–1,220 publications: 7 scientists 1,221–1,240 publications: 2 scientists 1,241–1,260 publications: 6 scientists 1,261–1,280 publications: 4 scientists 1,281–1,294 publications: 6 scientists 1,295+ publications: 100 scientists
61 publications 1,295+

This scientist: 158 publications — 17th percentile

17% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,295 publications or more.

Dan Gibson D-index placement in Chemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Chemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Dan Gibson sits on this spectrum.

40–41 D-Index: 289 scientists 42–43 D-Index: 612 scientists 44–45 D-Index: 808 scientists 46–47 D-Index: 776 scientists 48–49 D-Index: 835 scientists 50–51 D-Index: 861 scientists 52–53 D-Index: 872 scientists 54–55 D-Index: 933 scientists 56–57 D-Index: 1,051 scientists 58–59 D-Index: 930 scientists 60–61 D-Index: 882 scientists 62–63 D-Index: 834 scientists 64–65 D-Index: 731 scientists 66–67 D-Index: 775 scientists 68–69 D-Index: 683 scientists 70–71 D-Index: 646 scientists 72–73 D-Index: 561 scientists 74–75 D-Index: 501 scientists 76–77 D-Index: 437 scientists 78–79 D-Index: 388 scientists 80–81 D-Index: 354 scientists 82–83 D-Index: 292 scientists 84–85 D-Index: 275 scientists 86–87 D-Index: 254 scientists 88–89 D-Index: 235 scientists 90–91 D-Index: 185 scientists 92–93 D-Index: 192 scientists 94–95 D-Index: 155 scientists 96–97 D-Index: 163 scientists 98–99 D-Index: 125 scientists 100–101 D-Index: 105 scientists 102–103 D-Index: 105 scientists 104–105 D-Index: 112 scientists 106–107 D-Index: 88 scientists 108–109 D-Index: 68 scientists 110–111 D-Index: 69 scientists 112–113 D-Index: 65 scientists 114–115 D-Index: 79 scientists 116–117 D-Index: 61 scientists 118–119 D-Index: 44 scientists 120–121 D-Index: 37 scientists 122–123 D-Index: 40 scientists 124–125 D-Index: 33 scientists 126–127 D-Index: 26 scientists 128–129 D-Index: 34 scientists 130–131 D-Index: 35 scientists 132–133 D-Index: 25 scientists 134–135 D-Index: 27 scientists 136–137 D-Index: 17 scientists 138–139 D-Index: 16 scientists 140–141 D-Index: 20 scientists 142–143 D-Index: 20 scientists 144–145 D-Index: 15 scientists 146–147 D-Index: 9 scientists 148–149 D-Index: 9 scientists 150–151 D-Index: 16 scientists 152–153 D-Index: 11 scientists 154–155 D-Index: 9 scientists 156–157 D-Index: 3 scientists 158 D-Index: 3 scientists 159+ D-Index: 98 scientists
40 D-Index 159+

This scientist: 48 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 159 D-Index or more.

Overview

Dan Gibson is affiliated with the Hebrew University of Jerusalem in Israel. Their research primarily focuses on the intersection of medicine and chemistry, with significant contributions to oncology and organic chemistry.

Their published work spans several key subfields including oncology, organic chemistry, biomaterials, molecular biology, and biomedical engineering. The scientist's investigations often revolve around metal complexes synthesis and properties, with additional research exploring ferrocene chemistry and applications, nanoparticle-based drug delivery, click chemistry, nanoplatforms for cancer theranostics, adenosine and purinergic signaling, and asymmetric hydrogenation and catalysis.

Some of the recent papers authored or co-authored by Dan Gibson include:

  • Platinum(IV) anticancer agents; are we en route to the holy grail or to a dead end? (2021), Journal of Inorganic Biochemistry
  • A Multi-action and Multi-target RuII-PtIV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers (2020), Angewandte Chemie International Edition
  • Multiaction Pt(IV) Carbamate Complexes Can Codeliver Pt(II) Drugs and Amine Containing Bioactive Molecules (2020), Inorganic Chemistry
  • Are Pt(IV) Prodrugs That Release Combretastatin A4 True Multi-action Prodrugs? (2021), Journal of Medicinal Chemistry
  • Platinum(IV)-Estramustine Multiaction Prodrugs Are Effective Antiproliferative Agents against Prostate Cancer Cells (2020), Journal of Medicinal Chemistry

The scientist frequently collaborates with several researchers including Tomer Babu, Hana Kostrhunová, Viktor Brabec, Vojtěch Novohradský, and Subhendu Karmakar.

Dan Gibson's work has been published mostly in journals such as:

  • Journal of Medicinal Chemistry
  • Angewandte Chemie International Edition
  • Angewandte Chemie
  • Dalton Transactions
  • Chemistry & Biodiversity

The main fields of study that Dan Gibson contributes to are medicine and chemistry, with a particular focus on therapeutic strategies in oncology. Their research addresses the synthesis and properties of metal complexes and explores applications in drug delivery systems and anticancer therapies. The topics bridge chemistry and biomedical research, reflecting interdisciplinary approaches to developing anticancer agents and exploring prodrug mechanisms.

Best Publications

  • ISOLATION AND STRUCTURE OF A BRAIN CONSTITUENT THAT BINDS TO THE CANNABINOID RECEPTOR

    William A. Devane;Lumir Hanuš;Aviva Breuer;Roger G. Pertwee

  • X-ray structure of the major adduct of the anticancer drug cisplatin with DNA: cis-[Pt(NH3)2(d(pGpG))]

    Suzanne E. Sherman;Dan Gibson;Andrew H.-J. Wang;Stephen J. Lippard

  • What do we know about the reduction of Pt(IV) pro-drugs?

    Ezequiel Wexselblatt;Dan Gibson

  • Platinum(IV) anticancer prodrugs – hypotheses and facts

    Dan Gibson

  • Crystal and molecular structure of cis-[Pt(NH3)2{d(pGpG)}], the principal adduct formed by cis-diamminedichloroplatinum(II) with DNA

    Suzanne E. Sherman;Dan. Gibson;Andrew H. J. Wang;Stephen J. Lippard

  • Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studies.

    Olga Aronov;Aviva T. Horowitz;and Alberto Gabizon;Dan Gibson

  • Pt(IV) analogs of oxaliplatin that do not follow the expected correlation between electrochemical reduction potential and rate of reduction by ascorbate

    Jenny Z. Zhang;Ezequiel Wexselblatt;Trevor W. Hambley;Dan Gibson

  • The mechanism of action of platinum anticancer agents—what do we really know about it?

    Dan Gibson

  • A Multi-action and Multi-target Ru II -Pt IV Conjugate Combining Cancer-Activated Chemotherapy and Photodynamic Therapy to Overcome Drug Resistant Cancers.

    Johannes Karges;Thirumal Yempala;Mickaël Tharaud;Dan Gibson

  • Pt( iv ) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action

    Raji Raveendran;Jeremy Phillip Braude;Ezequiel Wexselblatt;Vojtech Novohradsky

  • Is glutathione the major cellular target of cisplatin? A study of the interactions of cisplatin with cancer cell extracts.

    Yonit Kasherman;Stefan Sturup;Dan Gibson

  • Multi-action Pt(IV) anticancer agents; do we understand how they work?

    Dan Gibson

  • Interactions of cisplatin and transplatin with proteins. Comparison of binding kinetics, binding sites and reactivity of the Pt-protein adducts of cisplatin and transplatin towards biological nucleophiles.

    Tal Peleg-Shulman;Yousef Najajreh;Dan Gibson

  • Triple action Pt(IV) derivatives of cisplatin: a new class of potent anticancer agents that overcome resistance

    Emanuele Petruzzella;Roman Sirota;Irene Solazzo;Valentina Gandin

  • Synthesis and antitumor activity of quinonoid derivatives of cannabinoids.

    Natalya M Kogan;Ruth Rabinowitz;Paloma Levi;Dan Gibson

  • A Quadruple-Action Platinum(IV) Prodrug with Anticancer Activity Against KRAS Mutated Cancer Cell Lines.

    Emanuele Petruzzella;Jeremy Phillip Braude;Janice R. Aldrich-Wright;Valentina Gandin

  • DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.

    Jana Kasparkova;Victoria Marini;Yousef Najajreh;Dan Gibson

  • Facile Preparation of Mono‐, Di‐ and Mixed‐Carboxylato Platinum(IV) Complexes for Versatile Anticancer Prodrug Design

    Jenny Z. Zhang;Paul Bonnitcha;Ezequiel Wexselblatt;Alice V. Klein

  • Novel soluble cationic trans-diaminedichloroplatinum(II) complexes that are active against cisplatin resistant ovarian cancer cell lines.

    Yousef Najajreh;Jose Manuel Perez;Carmen Navarro-Ranninger;Dan Gibson

  • Reduction of cis,trans,cis-[PtCl2(OCOCH3)2(NH3)2] by aqueous extracts of cancer cells.

    Alina Nemirovski;Yonit Kasherman;Yael Tzaraf;Dan Gibson

  • New insights into the molecular and epigenetic effects of antitumor Pt(IV)-valproic acid conjugates in human ovarian cancer cells.

    Vojtech Novohradsky;Lenka Zerzankova;Jana Stepankova;Oldrich Vrana

  • A mass spectral study of the binding of the anticancer drug cisplatin to ubiquitin

    Dan Gibson;Catherine E. Costello

Frequent Co-Authors

Viktor Brabec
Viktor Brabec Czech Academy of Sciences
Jana Kasparkova
Jana Kasparkova Czech Academy of Sciences
Rafik Karaman
Rafik Karaman Al-Quds University
Valentina Gandin
Valentina Gandin University of Padua
Michael Chorev
Michael Chorev Harvard University
Simon Benita
Simon Benita Hebrew University of Jerusalem
Yechezkel Barenholz
Yechezkel Barenholz Hebrew University of Jerusalem
Janice R. Aldrich-Wright
Janice R. Aldrich-Wright Western Sydney University
Andrew H.-J. Wang
Andrew H.-J. Wang Academia Sinica

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in Chemistry, exploring related fields such as forensic science and criminal justice can open diverse career opportunities. Many online colleges for forensic science offer affordable and flexible programs that integrate chemical principles with practical investigative skills.

Additionally, pursuing forensic psychology graduate programs online provides an interdisciplinary approach, combining psychological insights with forensic applications. These programs are ideal for those looking to understand human behavior within legal contexts.

Careers in forensics are expanding rapidly, including roles like forensic chemists, crime lab analysts, and forensic toxicologists. These careers often require specialized knowledge in both chemistry and criminal investigation, making related online degrees valuable for professional growth.

When considering these paths, it's important to evaluate factors such as tuition and fees. Many students find that enrolling in a criminal justice degree online can be a cost-effective way to gain the necessary foundational knowledge while balancing work and life commitments.

For more detailed information on programs and options, check out online colleges for forensic science, forensic psychology graduate programs online, careers in forensics, and criminal justice degree online cost.

Best Scientists Citing Dan Gibson

Trending Scientists

Recently Published Articles